ResMed | RMD - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Ansell USD 880.1M 465.65M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Fisher & Paykel Healthcare NZD 869.6M 67.2M 2026-06
Healius AUD 684.9M 261.2M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Nanosonics AUD 93.11M 45.89M 2025-12
Polynovo AUD 68.22M 1.24M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
Regis Healthcare AUD 643.07M 71.47M 2025-12
ResMed USD 931.6M 9.09M 2026-03
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Telix Pharmaceuticals AUD 430.99M 25.59M 2026-06